NCT01474668

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects

A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14c]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 5 (actual)
• Sponsor: Genentech, Inc. · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study will be an open-label, non-randomized, absorption, metabolism, and excretion study of \[14C\]-GDC 0941 administered as an oral dose to 6 healthy male subjects following at least a 10-hour fast from food (not including water).

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	GDC-0941	Single oral dose\\n \\n\\n\\n\\n

Timeline

• Start date: 2011-10-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2011-11-18
• Last updated: 2016-11-02

Locations

1 site across 1 country: United States